The Scientist

» biotech and developmental biology

Most Recent

On Tuesday, shareholders at the agribusiness giant approved the $66 billion deal with the European pharmaceutical firm.

0 Comments

image: Famed Mammalian Embryologist Dies

Famed Mammalian Embryologist Dies

By Jef Akst | December 2, 2016

Andrzej Tarkowski’s research laid the groundwork for future advances in cloning, stem cell research, and in vitro fertilization.

0 Comments

image: How to Track Cell Lineages As They Develop

How to Track Cell Lineages As They Develop

By Kelly Rae Chi | December 1, 2016

Sequencing and gene-editing advances make tracing a cells journey throughout development easier than ever.

0 Comments

image: Oligonucleotide Therapeutics Near Approval

Oligonucleotide Therapeutics Near Approval

By Catherine Offord | December 1, 2016

Successful late-stage clinical trials could mark the maturation of a new drug development platform, but the path to commercialization is not without hurdles.

0 Comments

image: Live Imaging Using Light-Sheet Microscopy

Live Imaging Using Light-Sheet Microscopy

By Kelly Rae Chi | November 1, 2016

How to make the most of this rapidly developing technique and a look at what's on the horizon

0 Comments

image: Opinion: Aging, Just Another Disease

Opinion: Aging, Just Another Disease

By Mutaz Musa | November 1, 2016

No longer considered an inevitability, growing older should be and is being treated like a chronic condition. 

26 Comments

image: Bridging a Gap in the Brain

Bridging a Gap in the Brain

By Ben Andrew Henry | October 12, 2016

Neuroscientists identify how the left and right hemispheres of the mammalian brain connect during development.

0 Comments

image: Further Support for Early-Life Allergen Exposure

Further Support for Early-Life Allergen Exposure

By Jef Akst | September 20, 2016

Egg and peanut consumption during infancy is linked to lower risk of allergy to those foods later in life, according to a meta-analysis.

0 Comments

Scientists estimate the risk to fetuses exposed to the virus in utero.

0 Comments

image: Another CRISPR Biotech Goes Public

Another CRISPR Biotech Goes Public

By Bob Grant | September 12, 2016

CRISPR Therapeutics, the company started by a pioneer of the gene editing technology, plans to raise $90 million from an initial public offering.

0 Comments

Popular Now

  1. How to Separate the Science From the (Jerk) Scientist
  2. Could a Dose of Sunshine Make You Smarter?
  3. Sweden Cancels Agreement With Elsevier Over Open Access
  4. Researchers Develop a Drug Against the Common Cold